Related Experiment Video

Updated: Jun 7, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

Ovarian function in girls and women with GALT-deficiency galactosemia

Judith L Fridovich-Keil1, Cynthia S Gubbels, Jessica B Spencer

  • 1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA. jfridov@emory.edu

Journal of Inherited Metabolic Disease
|October 28, 2010
PubMed

Insights

Premature ovarian insufficiency (POI) affects over 80% of women with classic galactosemia, even with early diagnosis and diet. This review examines POI detection, causes, and management strategies for galactosemia patients.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Reproductive Health

Background:

  • Classic galactosemia is a metabolic disorder requiring strict dietary management.
  • Premature ovarian insufficiency (POI) is a frequent and significant long-term complication in affected individuals.
  • High prevalence of POI (over 80-90%) persists despite neonatal screening and lifelong galactose restriction.

Purpose of the Study:

  • To review the complexities surrounding the timing and detection of galactosemia-associated POI.
  • To discuss potential underlying mechanisms contributing to POI in this population.
  • To provide recommendations for follow-up care and current intervention options.

Main Methods:

  • Literature review of studies on galactosemia and POI.
  • Analysis of diagnostic criteria and monitoring protocols for POI.
  • Exploration of proposed pathophysiological mechanisms of galactosemia-induced ovarian damage.

Main Results:

  • POI is a near-universal complication in classic galactosemia, occurring despite early diagnosis and dietary adherence.
  • Current understanding of POI mechanisms in galactosemia remains incomplete.
  • Effective management strategies and timely interventions are crucial for affected individuals.

Conclusions:

  • Early and ongoing monitoring for POI is essential for all individuals with classic galactosemia.
  • Further research into POI pathogenesis is needed to develop targeted therapies.
  • Comprehensive care plans integrating endocrine and reproductive health support are recommended.

More Related Videos

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice06:49

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice

Published on: February 12, 2018

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Oogenesis01:22

Oogenesis

Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...